Expression of matrix-metalloproteinases and their inhibitors in human cholesteatomas

Schonermark M, Mester B, Kempf HG, Blaser J, Tschesche H, Lenarz T (1996)
ACTA OTO-LARYNGOLOGICA 116(3): 451-456.

Journal Article | Published | English

No fulltext has been uploaded

Author
; ; ; ; ;
Abstract
The proteolytic erosion of the temporal bone is the key event in the pathognomonic course of cholesteatoma progression. The molecular mechanisms of bone resorption, endangering the ossicles, the inner ear, the facial nerve, large vessels or the brain, are not understood. Recently, a new family of proteolytic enzymes, the matrix-metalloproteinases (MMP's) has been described and identified, which seems to play a pivotal role in matrix- and bone homeostasis and inflammatory osteolytic diseases, e.g. osteoarthritis and periodontitis. These enzymes are sophisticatedly controlled by specific inhibitors and activation cascades. We investigated whether human cholesteatoma tissue expresses MMP's and MMP-inhibitors. By immunocytochemistry of cholesteatoma-cryosections, the expression of MMP-2 (72 kD collagenase), MMP-9 (92 kD collagenase), and MMP-3 (stromelysin-1) could be seen to be strictly confined to the basal and suprabasal cell layer of the cholesteatoma epithelium. The neutrophil collagenase (MMP-1) showed a more disseminated expression in the epithelium and the granulation tissue as well. The tissue inhibitor of metalloproteases, TIMP-1, could be detected only in very limited areas of the granulation tissue in a quite randomized manner. Therefore, a derailment in favor of proteolysis of the normally tightly controlled MMP-system might be postulated. The results indicate that members of the MMP-family could play an active role in the molecular mechanisms of cholesteatoma invasion into the temporal bone. This offers new insights into the pathophysiology of the disease and of potential therapeutic approaches.
Publishing Year
ISSN
eISSN
PUB-ID

Cite this

Schonermark M, Mester B, Kempf HG, Blaser J, Tschesche H, Lenarz T. Expression of matrix-metalloproteinases and their inhibitors in human cholesteatomas. ACTA OTO-LARYNGOLOGICA. 1996;116(3):451-456.
Schonermark, M., Mester, B., Kempf, H. G., Blaser, J., Tschesche, H., & Lenarz, T. (1996). Expression of matrix-metalloproteinases and their inhibitors in human cholesteatomas. ACTA OTO-LARYNGOLOGICA, 116(3), 451-456.
Schonermark, M., Mester, B., Kempf, H. G., Blaser, J., Tschesche, H., and Lenarz, T. (1996). Expression of matrix-metalloproteinases and their inhibitors in human cholesteatomas. ACTA OTO-LARYNGOLOGICA 116, 451-456.
Schonermark, M., et al., 1996. Expression of matrix-metalloproteinases and their inhibitors in human cholesteatomas. ACTA OTO-LARYNGOLOGICA, 116(3), p 451-456.
M. Schonermark, et al., “Expression of matrix-metalloproteinases and their inhibitors in human cholesteatomas”, ACTA OTO-LARYNGOLOGICA, vol. 116, 1996, pp. 451-456.
Schonermark, M., Mester, B., Kempf, H.G., Blaser, J., Tschesche, H., Lenarz, T.: Expression of matrix-metalloproteinases and their inhibitors in human cholesteatomas. ACTA OTO-LARYNGOLOGICA. 116, 451-456 (1996).
Schonermark, M, Mester, B, Kempf, HG, Blaser, J, Tschesche, Harald, and Lenarz, T. “Expression of matrix-metalloproteinases and their inhibitors in human cholesteatomas”. ACTA OTO-LARYNGOLOGICA 116.3 (1996): 451-456.
This data publication is cited in the following publications:
This publication cites the following data publications:

8 Citations in Europe PMC

Data provided by Europe PubMed Central.

Increased permeability of the epithelium of middle ear cholesteatoma.
Koizumi H, Suzuki H, Ohbuchi T, Kitamura T, Hashida K, Nakamura M., Clin Otolaryngol 40(2), 2015
PMID: 25319490
Possible participation of acidic pH in bone resorption in middle ear cholesteatoma.
Nguyen KH, Suzuki H, Ohbuchi T, Wakasugi T, Koizumi H, Hashida K, Baba R, Morimoto H, Doi Y., Laryngoscope 124(1), 2014
PMID: 24122656
Cholesteatoma-associated fibroblasts modulate epithelial growth and differentiation through KGF/FGF7 secretion.
Raffa S, Leone L, Scrofani C, Monini S, Torrisi MR, Barbara M., Histochem. Cell Biol. 138(2), 2012
PMID: 22481617
The role of inflammatory mediators in the pathogenesis of otitis media and sequelae.
Juhn SK, Jung MK, Hoffman MD, Drew BR, Preciado DA, Sausen NJ, Jung TT, Kim BH, Park SY, Lin J, Ondrey FG, Mains DR, Huang T., Clin Exp Otorhinolaryngol 1(3), 2008
PMID: 19434244
The pathophysiology of cholesteatoma.
Semaan MT, Megerian CA., Otolaryngol. Clin. North Am. 39(6), 2006
PMID: 17097438
Gene expression analysis of human middle ear cholesteatoma using complementary DNA arrays.
Tokuriki M, Noda I, Saito T, Narita N, Sunaga H, Tsuzuki H, Ohtsubo T, Fujieda S, Saito H., Laryngoscope 113(5), 2003
PMID: 12792315

25 References

Data provided by Europe PubMed Central.

Collagenolytic activity in middle ear cholesteatoma.
Abramson M., Ann. Otol. Rhinol. Laryngol. 78(1), 1969
PMID: 4303159
Matrix metalloproteinases: a review.
Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA., Crit. Rev. Oral Biol. Med. 4(2), 1993
PMID: 8435466

Murphy, Ann NY Acad Sci 732(), 1994
Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis.
Stetler-Stevenson WG, Liotta LA, Kleiner DE Jr., FASEB J. 7(15), 1993
PMID: 8262328

McCulloch, Ann NY Acad Sci 732(), 1994
Clinical importance of metalloproteinases and their inhibitors.
Krane SM., Ann. N. Y. Acad. Sci. 732(), 1994
PMID: 7978783

Vaes, Matrix (), 1992
Enzyme linked immunosorbent assays (ELISA) for the quantitative determination of human leukocyte collagenase and gelatinase.
Bergmann U, Michaelis J, Oberhoff R, Knauper V, Beckmann R, Tschesche H., J. Clin. Chem. Clin. Biochem. 27(6), 1989
PMID: 2547014
A semicontinuous, high-performance liquid chromatography-based assay for stromelysin.
Harrison R, Teahan J, Stein R., Anal. Biochem. 180(1), 1989
PMID: 2479283

Enghild, J Biol Chem 264(), 1989
Degradation of basement membranes by human matrix metalloproteinase 3 (stromelysin).
Bejarano PA, Noelken ME, Suzuki K, Hudson BG, Nagase H., Biochem. J. 256(2), 1988
PMID: 3223920

Lang, Laryngorhinotologie 73(), 1994

AUTHOR UNKNOWN, 0
Localization of interleukin-1 in human cholesteatoma.
Ahn JM, Huang CC, Abramson M., Am J Otolaryngol 11(2), 1990
PMID: 2188520

Dallari, Acta Otolaryngol (Stockh) 114(), 1994
Action of collagenase and elastase from human polymorphonuclear leukocytes on human articular cartilage.
Baici A, Salgam P, Cohen G, Fehr K, Boni A., Rheumatol. Int. 2(1), 1982
PMID: 6294813
Modulation of bone resorption by tetracyclines.
Rifkin BR, Vernillo AT, Golub LM, Ramamurthy NS., Ann. N. Y. Acad. Sci. 732(), 1994
PMID: 7978789

Woessner, J Rheumatol 18(), 1991

Buttice, Nucleic Acids Res 13(), 1991

Moriyama, Arch Otorhinolaryngol 230(), 1984

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 8790747
PubMed | Europe PMC

Search this title in

Google Scholar